Article Text

Download PDFPDF
The anti-tumor immune responses induced by a fusion protein of ovarian carcinoma anti-idiotypic antibody 6B11ScFv and murine GM-CSF in BALB/c mice
  1. H. Cui,
  2. X.-H. Chang,
  3. B. Liu,
  4. J. Feng,
  5. Y. Li,
  6. X. Ye,
  7. S.-J. Cao,
  8. T.-Y. Fu,
  9. Y. Yao,
  10. H.-N. Qian and
  11. H.-Q. Li
  1. Gynecologic Oncology Center, Peking University People's Hospital, Beijing, P.R. China
  2. Jenner Biotech Institute, Tianjin, R.O. China
  1. Address correspondence and reprint requests to: Heng Cui, Gynecologic Oncology Center, Peking University People's Hospital, Beijing, R.O. China. E-mail: cuiheng20{at}


Ovarian carcinoma anti-idiotypic antibody 6B11 was murine derived; we previously have cloned 6B11 single-chain Fv antibody (6B11ScFv) and constructed the 6B11ScFv/human granulocyte-macrophage colony stimulating factor (GM-CSF) fusion protein (designated as 6B11GM) to enhance the immunogenecity of the single-chain Ab2. Because of the difference in species specificity between human GM-CSF and murine GM-CSF, there is no immune competent animal model on which the effect and metabolism of 6B11GM as a vaccine could be observed. In this study, 6B11mGM fusion gene was constructed by the fusing murine GM-CSF cDNA gene with 6B11ScFv. The fusion gene was cloned and expressed. The product of this gene is a fusion protein. It could specifically interact with the primary anti-ovarian carcinoma monoclonal antibody (COC166-9) and rat anti-mouse GM-CSF monoclonal antibody, respectively, and stimulate the growth of NFS-60 cells (a murine GM-CSF-dependent cell line). The specific anti-tumor immune response could be induced in BALB/c mice after immunized with anti-idiotypic fusion protein instead of ovarian carcinoma antigen without carrier proteins and adjuvant. Ab3 could be detected in the sera of immunized mice with 6B11mGM by enzyme-linked immunoadsorbent assay test. Moreover, the fusion protein stimulated proliferation of CD4+ T cell from the spleen of BALB/c mice and proliferation of CD8+ T cell to a lesser degree. Therefore, 6B11mGM probably induces both humoral and cellular immunity against ovarian carcinoma in vivo.

  • antibody
  • anti-idiotype
  • ovarian carcinoma
  • recombinant fusion protein
  • tumor vaccine

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.